BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31875147)

  • 21. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
    Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.
    Isidean SD; Mayrand MH; Ramanakumar AV; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):923-929. PubMed ID: 28096198
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of p16
    Song F; Belinson JL; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    Gynecol Oncol; 2021 Aug; 162(2):322-330. PubMed ID: 34059349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
    Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
    Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
    Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
    Luttmer R; De Strooper LM; Steenbergen RD; Berkhof J; Snijders PJ; Heideman DA; Meijer CJ
    Expert Rev Mol Diagn; 2016 Sep; 16(9):961-74. PubMed ID: 27459506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral.
    Moy LM; Zhao FH; Li LY; Ma JF; Zhang QM; Chen F; Song Y; Hu SY; Balasubramanian A; Pan QJ; Koutsky L; Zhang WH; Lim JM; Qiao YL; Sellors JW
    Int J Cancer; 2010 Aug; 127(3):646-56. PubMed ID: 19960441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
    Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptima HPV Assay versus Hybrid Capture
    Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
    J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
    Coldman AJ; Phillips N; van Niekerk D; Smith L; Krajden M; Cook D; Quinlan DJ; Ehlen T; Miller D; Stuart GC; Peacock S; Martin RE; Franco EL; Ogilvie G
    J Obstet Gynaecol Can; 2015 May; 37(5):412-420. PubMed ID: 26168101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
    Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
    J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
    Grimes DR; Corry EMA; Malagón T; O'Riain C; Franco EL; Brennan DJ
    JAMA Netw Open; 2021 Jun; 4(6):e2115321. PubMed ID: 34190993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?
    Caeiro V; Nunes S; Esteves B; Moutinho-Fonseca J
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1907-1912. PubMed ID: 34181350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Visual Inspection Methods with Pap Smear as Screening Test for Premalignant Lesions of the Cervix.
    Yadav J; Agarwal S; Jain A
    J Midlife Health; 2024; 15(1):19-24. PubMed ID: 38764929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of cervical cancer and role of screening in India.
    Bobdey S; Sathwara J; Jain A; Balasubramaniam G
    Indian J Med Paediatr Oncol; 2016; 37(4):278-285. PubMed ID: 28144096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to adoption of recent technology in cervical screening.
    Jhala D; Eltoum I
    Cytojournal; 2007 Aug; 4():16. PubMed ID: 17705820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.